Low levels of endothelial progenitor cells correlate with disease duration and activity in patients with Behçet's disease

Clin Exp Rheumatol. 2009 Sep-Oct;27(5):814-21.

Abstract

Objectives: We tested whether Behçet's disease (BD) is characterized by alterations of circulating endothelial progenitor cells (EPCs),which are involved in vascular homeostasis and repair.

Methods: We enrolled 30 BD patients and 27 matched healthy controls. EPCs were defined and measured by flow cytometry according to the expression of CD34, CD133 and KDR.

Results: We show that BD patients had significantly lower levels of CD34+KDR+ and CD34+CD133+KDR+ EPCs than controls. We found significant negative correlations between EPC phenotypes and BD duration, while there were positive correlations between CD34+KDR+ EPCs and both BD activity scores and C-reactive protein. The lower EPC levels with increasing disease duration was shown in univariate analysis and in multivariable analysis adjusted for possible confounders.

Conclusion: This is the first report that BD is associated with progressive EPC decline. Reduction of EPCs may represent a mechanism of induction and/or progression of vascular injury in these patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AC133 Antigen
  • Adult
  • Antigens, CD
  • Antigens, CD34
  • Behcet Syndrome / blood*
  • Blood Cell Count
  • C-Reactive Protein / analysis
  • Case-Control Studies
  • Endothelial Cells / metabolism*
  • Flow Cytometry
  • Glycoproteins
  • Humans
  • Male
  • Peptides
  • Severity of Illness Index
  • Stem Cells / metabolism*
  • Vascular Endothelial Growth Factor Receptor-2

Substances

  • AC133 Antigen
  • Antigens, CD
  • Antigens, CD34
  • Glycoproteins
  • PROM1 protein, human
  • Peptides
  • C-Reactive Protein
  • Vascular Endothelial Growth Factor Receptor-2